| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Guardant Health, Inc. (GH) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. GH is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.03M | $261.30M | -100,000 | |
| Other | 79.1K | $10.19M | - | |
| CFO | 47.5K | $6.12M | -2,000 | |
| Other | 46.7K | $6.02M | - | |
| Other | 36.0K | $4.63M | -10,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2020 | Meresman Stanley J75 | Director | Sale+OE | 2,000 | $82.02 | $164,040.00 | -60.6% | |
| Feb 3, 2020 | Clark Ian T66 | Director | Sale+OE | 2,690 | $76.23 | $205,058.70 | -67.4% | |
| Jan 27, 2020 | Clark Ian T66 | Director | Sale+OE | 538 | $77.31 | $41,592.78 | -29.2% | |
| Jan 15, 2020 | Meresman Stanley J75 | Director | Sale+OE | 5,000 | $79.55 | $397,750.00 | -79.3% | |
| Jan 3, 2020 | Clark Ian T66 | Director | Sale+OE | 2,690 | $77.87 | $209,470.30 | -67.4% | |
| Dec 26, 2019 | Clark Ian T66 | Director | Sale+OE | 538 | $82.69 | $44,487.22 | -29.2% | |
| Dec 23, 2019 | Wiley Michael J | Chief Legal Officer | Sale+OE | 6,148 | $81.67 | $502,097.86 | -1.7% | |
| Dec 20, 2019 | Talasaz Amirali | Chairman, President And COO | Sale+OE | 25,219 | $82.73 | $2,086,390.64 | -0.4% | |
| Dec 19, 2019 | Talasaz Amirali | Chairman, President And COO | Sale+OE | 247,919 | $80.71 | $20,009,043.36 | -2.3% | |
| Dec 19, 2019 | Wiley Michael J | Chief Legal Officer | Sell | 43,000 | $79.68 | $3,426,321.52 | -9.5% |